GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient ▲ Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA
Patient 1
10
moderate
416
IgA
Patient 1
10
moderate
376
IgA
Patient 1
10
moderate
432
IgA
Patient 1
10
moderate
375
IgA
Patient 1
10
moderate
337
IgA
Patient 1
10
moderate
403
IgA
Patient 1
10
moderate
374
IgA
Patient 1
10
moderate
444
IgA
Patient 1
10
moderate
424
IgA
Patient 1
10
moderate
391
Displaying entries 101 - 110 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01